Indo Us Bio-Tech Limited (BOM:541304)
India
· Delayed Price · Currency is INR 156.55
+4.15 (2.72%)
At close: Jul 4, 2025
Indo Us Bio-Tech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,038 | 728.36 | 617.45 | 500.59 | 401.1 | Upgrade
|
| 1,038 | 728.36 | 617.45 | 500.59 | 401.1 | Upgrade
| |
Revenue Growth (YoY) | 42.56% | 17.96% | 23.34% | 24.80% | 0.88% | Upgrade
|
Cost of Revenue | 726.58 | 466.39 | 433.94 | 343.51 | 242.87 | Upgrade
|
Gross Profit | 311.81 | 261.97 | 183.5 | 157.08 | 158.23 | Upgrade
|
Selling, General & Admin | 10.94 | 39.58 | 31.48 | 25.53 | 16.13 | Upgrade
|
Other Operating Expenses | 109.71 | 111.37 | 58.05 | 62.09 | 88.32 | Upgrade
|
Operating Expenses | 131.62 | 158.95 | 97.79 | 92.09 | 107.04 | Upgrade
|
Operating Income | 180.19 | 103.02 | 85.71 | 64.99 | 51.2 | Upgrade
|
Interest Expense | -14.88 | -14.1 | -11.24 | -11.45 | -11.22 | Upgrade
|
Interest & Investment Income | - | 0.12 | - | 0.03 | 0.02 | Upgrade
|
Other Non Operating Income (Expenses) | -0 | -1 | -0.6 | -0.46 | -0.58 | Upgrade
|
EBT Excluding Unusual Items | 165.31 | 88.04 | 73.87 | 53.11 | 39.41 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | -0.12 | Upgrade
|
Pretax Income | 165.31 | 88.04 | 73.87 | 53.11 | 39.29 | Upgrade
|
Income Tax Expense | 2.63 | 5.53 | 1.46 | 2.48 | -9.71 | Upgrade
|
Net Income | 162.67 | 82.51 | 72.4 | 50.63 | 49 | Upgrade
|
Net Income to Common | 162.67 | 82.51 | 72.4 | 50.63 | 49 | Upgrade
|
Net Income Growth | 97.15% | 13.96% | 43.00% | 3.34% | 93.30% | Upgrade
|
Shares Outstanding (Basic) | 20 | 20 | 19 | 12 | 15 | Upgrade
|
Shares Outstanding (Diluted) | 20 | 20 | 19 | 12 | 15 | Upgrade
|
Shares Change (YoY) | -0.09% | 3.95% | 57.60% | -15.96% | - | Upgrade
|
EPS (Basic) | 8.12 | 4.11 | 3.75 | 4.14 | 3.36 | Upgrade
|
EPS (Diluted) | 8.12 | 4.11 | 3.75 | 4.13 | 3.36 | Upgrade
|
EPS Growth | 97.57% | 9.50% | -9.22% | 22.97% | 93.19% | Upgrade
|
Free Cash Flow | 5.57 | -71.92 | -12.97 | -12.64 | -17.95 | Upgrade
|
Free Cash Flow Per Share | 0.28 | -3.59 | -0.67 | -1.03 | -1.23 | Upgrade
|
Dividend Per Share | - | - | - | 0.125 | - | Upgrade
|
Gross Margin | 30.03% | 35.97% | 29.72% | 31.38% | 39.45% | Upgrade
|
Operating Margin | 17.35% | 14.14% | 13.88% | 12.98% | 12.76% | Upgrade
|
Profit Margin | 15.67% | 11.33% | 11.73% | 10.12% | 12.22% | Upgrade
|
Free Cash Flow Margin | 0.54% | -9.87% | -2.10% | -2.52% | -4.48% | Upgrade
|
EBITDA | 191.17 | 111.03 | 93.97 | 69.45 | 53.79 | Upgrade
|
EBITDA Margin | 18.41% | 15.24% | 15.22% | 13.87% | 13.41% | Upgrade
|
D&A For EBITDA | 10.98 | 8 | 8.26 | 4.46 | 2.59 | Upgrade
|
EBIT | 180.19 | 103.02 | 85.71 | 64.99 | 51.2 | Upgrade
|
EBIT Margin | 17.35% | 14.14% | 13.88% | 12.98% | 12.76% | Upgrade
|
Effective Tax Rate | 1.59% | 6.28% | 1.98% | 4.67% | - | Upgrade
|
Revenue as Reported | 1,040 | 731.56 | 617.66 | 502.41 | 401.53 | Upgrade
|
Advertising Expenses | - | 0.26 | 0.06 | 0.22 | 1.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.